The chemical class known as stefin A2 activators encompasses a range of compounds that can play a role in the modulation of cellular protease inhibitor levels, particularly that of stefin A2, a cysteine protease inhibitor. These activators influence the cellular environment in ways that necessitate the activation or upregulation of stefin A2 to maintain proteolytic balance and cellular homeostasis. They operate through various mechanisms, such as inhibiting the proteasome, a complex responsible for degrading unneeded or damaged proteins, which can lead to an increase in the expression of natural protease inhibitors, including stefin A2. Additionally, some activators work by inducing cellular stress responses, which in turn can trigger the upregulation of protease inhibitors as part of the cell's mechanism to mitigate the effects of stress.
These activators include compounds that inhibit different proteases or modulate specific cellular pathways that indirectly lead to the increased expression of stefin A2. For instance, compounds that disrupt mitochondrial function can cause cellular stress, prompting a protective response that includes the activation of protease inhibitors. Similarly, agents that inhibit cysteine proteases, or those that affect cellular regulatory pathways, such as the PPARγ agonists or NRF2 activators, can result in the enhanced expression of stefin A2. These activators work by altering the intracellular milieu, which can lead to the cell bolstering its protective measures against proteolytic activity, thereby ensuring the integrity of cellular proteins and preventing the accumulation of damaged or misfolded proteins. This class of compounds, therefore, plays an integral role in the fine-tuning of protease activity and the safeguarding of cellular function by modulating the expression of stefin A2.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Citilistat | 282526-98-1 | sc-358100 sc-358100A | 250 mg 1 g | ¥519.00 ¥1151.00 | ||
这种化合物抑制线粒体丙酮酸转运,从而可能导致细胞应激,并可能激活蛋白酶抑制剂(如STFA2)的表达,以防止应激引起的蛋白酶活性。 | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | ¥632.00 ¥2933.00 ¥11056.00 | 163 | |
蛋白酶体抑制剂可能会导致蛋白质的积累,从而可能激活蛋白酶抑制剂(如 STFA2)的上调,以控制蛋白酶水平的增加。 | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | ¥3103.00 ¥10470.00 ¥17408.00 | 14 | |
一种不可逆的半胱氨酸蛋白酶抑制剂,有可能激活细胞增强天然蛋白酶抑制剂(包括 STFA2)的表达,以维持蛋白水解平衡。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | ¥1489.00 ¥12004.00 | 115 | |
作为一种蛋白酶体抑制剂,它可能会激活细胞对错误折叠蛋白质的反应,从而可能导致 STFA2 的表达增加。 | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | ¥812.00 ¥1636.00 ¥2990.00 ¥5517.00 ¥15784.00 ¥1117.00 | 19 | |
硫醇蛋白酶抑制剂可能会激活细胞上调内源性蛋白酶抑制剂(如 STFA2),以维持蛋白水解平衡。 | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | ¥1862.00 ¥6487.00 | 60 | |
这种蛋白酶体抑制剂可能会激活 STFA2 的上调,因为细胞会对未降解蛋白质的堆积做出反应。 | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | ¥609.00 ¥1388.00 | 13 | |
PPARγ 的激动剂会影响各种基因的表达,可能会激活 STFA2 等蛋白酶抑制剂的表达。 | ||||||
Dimethyl fumarate | 624-49-7 | sc-239774 | 25 g | ¥305.00 | 6 | |
激活 NRF2 通路,该通路可调节抗氧化应激酶的表达,并可能激活 STFA2 等蛋白酶抑制剂的表达。 | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | ¥835.00 | 256 | |
一种可能激活细胞应激反应的泛天冬酶抑制剂,有可能增加 STFA2 的表达。 | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | ¥587.00 ¥982.00 | 7 | |
醛脱氢酶抑制剂,可能会激活蛋白毒性应激,导致蛋白酶抑制剂(包括 STFA2)上调。 |